Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes

Pharmacology

Volumn 53, Issue 4, 1996, Pages 250-258

  Adachi, Shino ^a   Koike, Katsuo ^a   Takayanagi, Issei ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Indoline derivatives; M1 receptor; McN A 343; Muscarinic receptor; Rabbit vas deferens

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; INDOLINE DERIVATIVE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GUINEA PIG; HEART LEFT ATRIUM; ILEUM CONTRACTION; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR AFFINITY; SMOOTH MUSCLE CONTRACTION; VAS DEFERENS;

EID: 0029849776     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139437     Document Type: Article

References (28)

1. Hulme EC, Birdsall NJM, Buckley NJ: Muscarinic receptor subtypes, Annu Rev Pharmacol Toxicol 1990: 30:633-673.
2. Caulfield MP: Muscarinic receptors: Characterization, coupling and function, Pharmacol Ther 1993:58: 319-379.
3. Friebe TP, Mutschlcr E, Lambrecht G: Muscarinic receptor subtype: Pharmacological characterization, molecular structure, location, function and receptor-effector coupling, Pharm Ztg Wiss 1993;138:3-11.
4. Wess J: Molecular basis of muscarinic acetylcholine receptor function, Trends Pharmacol Sci 1993; 14:308-313.
5. Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC: Pi-renzeprine distinguishes between different subclasses of muscarinic receptors, Nature 1980:283:90-92.
6. Melchiorre C, Cassinelli A, Quaglia W: Differential blockade of muscarinic receptor subtypes by polyme-thylenc tetraamines, Novel class of selective antagonists of cardiac M-2 muscarinic receptors, J Med Chem 1987:30:201-204.
7. Hammer R, Giraldo E, Schiavi GB, Monfcrini E, Ladinsky H: Binding profile of a novel cardioseleclive muscarinic receptor antagonist, AF-DX116, to membranes of peripheral tissues and brain in the rat, Life Sci 1986:38:1653-1662.
8. Anwar-ul S, Gilani H, Cobbin LB: The cardioselectivity of himbacine: A muscarine receptor antagonist, Naunyn Schmicdcbergs Arch Pharmacol 1986:332:16-20.
9. Barlow RB, Berry KJ, Glenton PAM, Nikolaou NM, Soh KS: A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea pig atrial pacemaker cells at 29°C and in ileum at 29 °C and 37 °C, Br J Pharmacol 1976:58:613-620.
10. Lambrecht G, Feifel R, Forth B, Strohmann C, Tacke R, Mutschlcr E: p-Fluorohexahydrosiladiphcni-dol: The first M^-selective muscarinic antagonist, Eur.1 Pharmacol 1988:152:193-194.
11. Bonner TI, Buckley NJ, Young AC, Brann MR: Identification of a family of muscarinic acetylcholine receptor genes, Science 1987:237:527-532.
12. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR: Antagonist binding profiles of five cloned human muscarinic receptor subtypes, J Pharmacol Exp Ther 1991:256:727-733.
13. Eglen RM, Reddy H, Watson N, Whiting RL: Muscarinic receptor subtypes in smooth muscle, Trends Pharmacol Sei 1994:15:114-119.
14. Takayanagi I, Irikura T, Nishino K, Ohkubo H: A new parasympathomimetic agent: l-methyl-5-chloroin-doline methylbromide, Jpn J Pharmacol 1971:21:311-316.
15. Eltze M: Muscarinic Ml-and M2-rcceptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens, F.ur J Pharmacol 1988:151:205-221.
16. Eltze M, Gniclin G, Wess J, Strohmann C, Tacke R, Mutschler E, Lambrecht G: Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic Mi-type, Eur J Pharmacol 1988: 158:233-242.
17. Lambrecht G, Feifel R, Moser U, Aasen AJ, Waelbroeck M, Christophe J, Mutschler E: Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes, Eur J Pharmacol 1988:155:167-170.
18. Van Rossum JM: Cumulative dose-response curve, II, Techniques of making of dose-response curves in isolated organs and evaluation of drug parameters, Arch Int Pharma-codyn Thér 1963;143:299-330.
19. Arunlakshana O, Schild HO: Some quantitative uses of drug antagonist, Br J Pharmacol 1959;14:48-58.
20. Paton WDM, Rang HP: The kinetic approach to drug antagonism; in Harper NJ, Simmonds AB (cds): Advances in Drug Research, London, Academic Press, 1966, vol 3, pp 57-80.
21. Harada M, Koike K, Takayana-gi 1: Characterization of subtype of propvlbenzilylchoiine mustard (PrBCM)-sensitive and-resistant muscarinic cholinoceptors in guinea pig ileal muscle, Jpn J Pharmacol 1992;59:485-487.
22. Burgen ASV, Mitchell JF: General pharmacology; in Burgen ASV, Mitchell JF (cds): Gaddum’s Pharmacology, London, Oxford University Press, 1978, pp 1-12.
23. Hammer R, Giachetti A: Muscarinic receptor subtypes: M i and M; biochemical and functional characterization, Life Sci 1982:31:2991-2998.
24. Takayanagi I, Konno F, Toru T, Ta-kahashi R: Differences in mode of action of alphai-adrenoceptor antagonists on some vascular smooth muscles and efficacy, Jpn J Pharmacol 1986:42:237-241.
25. Paton WDM, Waud DR: The margin of safety of neuromuscular transmission, J Physiol 1967;191:59-90.
26. Kenakin TP: The classification of drugs and drug receptors in isolated tissues, Pharmacol Rev 1984:36: 165-222.
27. Doods HN, Mathy MJ, Davidesko D, Van Carldorp KL, De Jonge A, Van Zwieteu PA: Selectivity of muscarinic antagonists in radioligand and in vivo experiments for putative M, M2 and M3 receptor, J Pharmacol ExpThcr 1987;242:257-262.
28. Waclbroeck M, Tastenoy M, Camus J, Cristophc J: Binding of selective antagonists to four muscarinic receptors (M1-M4) in rat forebrain, Mol Pharmacol 1990;38:267-273.